Research progress on venous thrombosis development in patients with malignant tumors  

作　　者：Teng-Fei Wang Qian Chen Jie Deng Shi-Liang Li Yuan Xu Si-Xing Ma 

机构地区：[1]Department of Vascular Surgery,The Affiliated Hospital of Guizhou Medical University,Guiyang 550000,Guizhou Province,China [2]Department of Organ Transplantation,The Affiliated Hospital of Guizhou Medical University,Guiyang 550000,Guizhou Province,China

出　　处：《World Journal of Clinical Cases》2024年第11期1900-1908,共9页世界临床病例杂志

基　　金：Guizhou Provincial Basic Research Program,No.ZK2023376;Guizhou Provincial Health Commission Science and Technology Fund Project,No.GZWKJ2023164 and No.SYXK2018-0001;Guizhou Medical University Hospital National Natural Science Foundation Cultivation Project,No.GYFYnsfc-2021-36.

摘　　要：The coexistence of venous thromboembolism(VTE)within patients with cancer,known as cancer-associated thrombosis(CAT),stands as a prominent cause of mortality in this population.Over recent years,the incidence of VTE has demonstrated a steady increase across diverse tumor types,influenced by several factors such as patient management,tumor-specific risks,and treatment-related aspects.Furthermore,mutations in specific genes have been identified as potential contributors to increased CAT occurrence in particular cancer subtypes.We conducted an extensive review encompassing pivotal historical and ongoing studies on CAT.This review elucidates the risks,mechanisms,reliable markers,and risk assessment methodologies that can significantly guide effective interventions in clinical practice.

关 键 词：Malignant tumor Venous thromboembolism Cancer-associated thrombosis Research progress 

分 类 号：R714.25[医药卫生—妇产科学]